Prescription drug · ANDA
brivaracetam NDC 70710-1586
Brivaracetam 50 mg/1 · Tablet, Film coated · Oral · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-1586-4 | 70710158604 | 100 BLISTER PACK in 1 CARTON (70710-1586-4) / 1 TABLET, FILM COATED in 1 BLISTER PACK (70710-1586-7)Marketed from Feb 21, 2026 | |
| 70710-1586-6 | 70710158606 | 60 TABLET, FILM COATED in 1 BOTTLE (70710-1586-6)Marketed from Feb 21, 2026 | |
| 70710-1586-8 | 70710158608 | 180 TABLET, FILM COATED in 1 BOTTLE (70710-1586-8)Marketed from Feb 21, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214501
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 70710-1586_dd7c5f3e-5cd5-4219-bf1a-7fe15b291998SPL ID dd7c5f3e-5cd5-4219-bf1a-7fe15b291998SPL set ID d54ca946-2ddf-4a67-87c9-20a814bfd2dcRxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0370710158569, 0370710158668, 0370710158460, 0370710158767
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470710158604followed by a unit qualifier and the quantityPackage 70710-1586-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214501
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1755 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1754 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1758 |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1756 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1757 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1584 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1588 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1585 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1587 |